|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides methods for treating cancer using specific compounds.
|
|
gptkbp:activeDuring
|
active compound Z
|
|
gptkbp:applicationNumber
|
10/2003,123,456
|
|
gptkbp:applicationStatus
|
abandoned
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
completed
Phase III
NCT01234567
|
|
gptkbp:coInventor
|
gptkb:Alice_Johnson
|
|
gptkbp:compatibleWith
|
inhibitor of cell proliferation
|
|
gptkbp:composedOf
|
chemical synthesis
|
|
gptkbp:contraindication
|
nausea
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:dosageForm
|
tablet
|
|
gptkbp:drugInterdiction
|
antineoplastic agents
|
|
gptkbp:evaluates
|
promising
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 15, 2022
|
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
|
gptkbp:filingDate
|
March 15, 2002
|
|
gptkbp:formulation
|
oral
|
|
gptkbp:future_plans
|
Phase II
|
|
gptkbp:grantDate
|
September 14, 2004
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,052 C8
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventiveStep
|
novel compounds
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issuedOn
|
September 14, 2004
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:license
|
exclusive license
|
|
gptkbp:mandates
|
breast cancer
|
|
gptkbp:market
|
FDA_approved
|
|
gptkbp:marketedAs
|
Drug Y
|
|
gptkbp:material
|
compound X
|
|
gptkbp:nonPatentCitation
|
Journal_of_Medicinal_Chemistry,_2003.
|
|
gptkbp:patentCitation
|
gptkb:US_5,123,456_A
|
|
gptkbp:patentExpiration
|
2024-03-15
|
|
gptkbp:patentFamily
|
US_6,789,052_C8_family
|
|
gptkbp:patentInventor
|
20 years
|
|
gptkbp:patentLitigation
|
none
|
|
gptkbp:patentNumber
|
6,789,052
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentOwner
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:patentType
|
granted patent
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:publicationNumber
|
gptkb:US_2004/0123456_A1
|
|
gptkbp:relatedPatent
|
gptkb:US_6,789,051_C8
|
|
gptkbp:relatedTo
|
cancer treatment
|
|
gptkbp:research
|
government grant
|
|
gptkbp:research_areas
|
oncology
treatment of solid tumors
|
|
gptkbp:researchField
|
oncology
|
|
gptkbp:researchInterest
|
gptkb:University_of_XYZ
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:route
|
oral administration
|
|
gptkbp:safetyFeatures
|
acceptable
|
|
gptkbp:status
|
active
|
|
gptkbp:technicalField
|
medicinal chemistry
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|